Education
About Us
Working with TipRanks
Follow Us
IN8bio (INAB)
NASDAQ:INAB
Total Valuation
IN8bio has a market cap or net worth of $10.90M. The enterprise value is -$1.50M.
Market Cap$10.90M
Enterprise Value-$1.50M
Share Statistics
IN8bio has 4,539,717 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,539,717
Owned by Insiders23.83%
Owned by Institutions14.52%
Financial Efficiency
IN8bio’s return on equity (ROE) is -2.10 and return on invested capital (ROIC) is -151.73%.
Return on Equity (ROE)-2.10
Return on Assets (ROA)-1.45
Return on Invested Capital (ROIC)-151.73%
Return on Capital Employed (ROCE)-1.66
Revenue Per Employee0.00
Profits Per Employee-1.69M
Employee Count18
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of IN8bio is ―. IN8bio’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value28.55
Price to FCF―
Price to Operating Cash Flow-548.81
PEG Ratio―
Income Statement
In the last 12 months, IN8bio had revenue of 0.00 and earned -30.44M in profits. Earnings per share was -0.57.
Revenue0.00
Gross Profit-2.65M
Operating Income-29.60M
Pretax Income-30.44M
Net Income-30.44M
EBITDA-27.78M
Earnings Per Share (EPS)-0.57
Cash Flow
In the last 12 months, operating cash flow was -17.19M and capital expenditures 50.00K, giving a free cash flow of -17.14M billion.
Operating Cash Flow-17.19M
Free Cash Flow-17.14M
Free Cash Flow per Share-3.78
Dividends & Yields
IN8bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.58
52-Week Price Change-88.57%
50-Day Moving Average2.36
200-Day Moving Average6.09
Relative Strength Index (RSI)54.59
Average Volume (3m)125.73K
Important Dates
IN8bio upcoming earnings date is Nov 6, 2025, After Close (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
IN8bio as a current ratio of 4.08, with Debt / Equity ratio of 20.46%
Current Ratio4.08
Quick Ratio4.08
Debt to Market Cap<0.01
Net Debt to EBITDA0.22
Interest Coverage Ratio0.00
Taxes
In the past 12 months, IN8bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
IN8bio EV to EBITDA ratio is -14.66, with an EV/FCF ratio of -16.79.
EV to Sales0.00
EV to EBITDA-14.66
EV to Free Cash Flow-16.79
EV to Operating Cash Flow-16.87
Balance Sheet
IN8bio has $13.23M in cash and marketable securities with $3.12M in debt, giving a net cash position of -$10.11M billion.
Cash & Marketable Securities$13.23M
Total Debt$3.12M
Net Cash-$10.11M
Net Cash Per Share-$2.23
Tangible Book Value Per Share$0.27
Margins
Gross margin is -91.81%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-91.81%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for IN8bio is $3.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$3.00
Price Target Upside25.00% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast58.67%